Stage IIIC Uveal Melanoma AJCC v7 Completed Phase 3 Trials for Sargramostim (DB00020)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0106952 (Stage IIIC Uveal Melanoma AJCC v7) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01989572 | Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery | Prevention |